Medications

Poll: Many blame drug firms for opioid crisis

About two-thirds of Americans believe drug companies are to blame for the opioid crisis, although nearly as many hold drug users themselves responsible, a new poll finds.

Medications

Biostatistician helps FDA approve first biosimilar drug

Bernard "Chip" Cole got the call in late December. The U.S. Food and Drug Administration summoned the University of Vermont biostatistician for another mission. Since 2013, Cole has sat on an important FDA panel that assesses ...

Medical research

Clinical trials: Two arms are better than one

The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.

Medications

Nancy Pelosi unveils an ambitious plan to lower drug prices

Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance.

Medications

US targets Chinese firms in painkiller crackdown

The United States on Wednesday imposed sanctions on Chinese painkiller makers as it vowed to step up action to curb the addiction epidemic that killed a record 100,000 Americans last year.

Medications

Jury orders Gilead to pay Merck $2.5bn in patent case

A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.

page 26 from 40